>>SAN DIEGO--(BUSINESS WIRE)--Oct. 9, 2002-- CardioDynamics (Nasdaq: CDIC - News), the innovator and leader of Impedance Cardiography (ICG) technology and manufacturer of BioZ® noninvasive digital cardiac function monitoring systems, today announced the results of an important ICG clinical study by the California Heart Institute at Redding Medical Center (RMC), part of Tenet California. These results were recently presented at the Annual American College of Emergency Physicians Scientific Assembly in Seattle, WA.
The study's results indicated that the hemodynamic data derived from the BioZ significantly reduced the diagnosis time of patients seen at the emergency department with dyspnea (shortness of breath), hypoxia (deficiency of oxygen) or symptomatic hypotension (low blood pressure) when compared to standard ER evaluation. Evaluation and diagnosis time with the BioZ ICG was significantly faster (68.4 +/- 46.1 minutes) as compared to the time of a diagnosis by emergency department physicians (170.0 +/- 72.7 minutes).
Based on the study's preliminary results, Redding Medical Center announced in March of 2002 that it would be initiating a protocol throughout the critical care and emergency department for BioZ ICG testing in all patients complaining of dyspnea, or presenting hypoxia or hypotension.
"The study's results demonstrate the BioZ to be a rapid, noninvasive solution, allowing physicians to quickly assess, diagnose, customize and target treatment for their patients," said Charles L. Springfield, MD, FACEP, Medical Director of RMC Emergency Services. "In our population of dyspneic and hypotensive patients, we found ICG resulted in a more rapid determination of cardiac versus non-cardiac etiology. This allows for earlier intervention with equivalent accuracy and significant cost savings when compared with a comprehensive emergency department evaluation."
Michael K. Perry, Chief Executive Officer of CardioDynamics, stated, "This study further validates the importance of the BioZ in the estimated 7,800 emergency departments in the U.S. Emergency physicians are beginning to embrace the need for our ICG technology in order to potentially better treat their patients, improve outcomes, and substantially reduce costs. We are pleased with the building emergency market momentum alongside our better-established markets of congestive heart failure, high blood pressure, pacemaker and critical care."<<
snip
Cheers, Tuck |
